nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bacteraemia risk prediction model: development and validation in an emergency medicine population
|
Julián-Jiménez, Agustín |
|
|
50 |
1 |
p. 203-221 |
artikel |
2 |
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital
|
Jeck, Julia |
|
|
50 |
1 |
p. 191-201 |
artikel |
3 |
Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France
|
Carrat, Fabrice |
|
|
50 |
1 |
p. 257-262 |
artikel |
4 |
Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study
|
Shen, Qian |
|
|
50 |
1 |
p. 169-178 |
artikel |
5 |
A severe case of Israeli spotted fever with pleural effusion in Italy
|
Guccione, Cristoforo |
|
|
50 |
1 |
p. 269-272 |
artikel |
6 |
A spark of hope: histopathological and functional recovery after critical COVID-19
|
Boehm, Anna |
|
|
50 |
1 |
p. 263-267 |
artikel |
7 |
Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study
|
De Santis, Vincenzo |
|
|
50 |
1 |
p. 139-148 |
artikel |
8 |
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
|
Chong, Woon Hean |
|
|
50 |
1 |
p. 43-56 |
artikel |
9 |
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients
|
Malin, Jakob J. |
|
|
50 |
1 |
p. 107-108 |
artikel |
10 |
Correction to: Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century
|
Baumann, Sven |
|
|
50 |
1 |
p. 287-288 |
artikel |
11 |
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
|
Tabernero, Eva |
|
|
50 |
1 |
p. 179-189 |
artikel |
12 |
Detection of Zika virus in urine from randomly tested individuals in Mirassol, Brazil
|
da Conceição, Pâmela Jóyce Previdelli |
|
|
50 |
1 |
p. 149-156 |
artikel |
13 |
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis
|
Angamo, Mulugeta T. |
|
|
50 |
1 |
p. 27-41 |
artikel |
14 |
Ensuring global access to COVID-19 vaccines: deployment strategies for refugees and migrants must not be forgotten
|
Buonsenso, Danilo |
|
|
50 |
1 |
p. 273-275 |
artikel |
15 |
Key summary of German national treatment guidance for hospitalized COVID-19 patients
|
Malin, Jakob J. |
|
|
50 |
1 |
p. 93-106 |
artikel |
16 |
Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review
|
Zhu, Andrew |
|
|
50 |
1 |
p. 1-9 |
artikel |
17 |
Lobar (croupous) pneumonia: old and new data
|
Zinserling, Vsevolod A. |
|
|
50 |
1 |
p. 235-242 |
artikel |
18 |
Long COVID: current definition
|
Fernández-de-las-Peñas, César |
|
|
50 |
1 |
p. 285-286 |
artikel |
19 |
Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study
|
Lu, Justin Y. |
|
|
50 |
1 |
p. 109-119 |
artikel |
20 |
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
|
Russo, Alessandro |
|
|
50 |
1 |
p. 83-92 |
artikel |
21 |
Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections
|
Doub, James B. |
|
|
50 |
1 |
p. 281-283 |
artikel |
22 |
Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy
|
Malshe, Nandini |
|
|
50 |
1 |
p. 131-137 |
artikel |
23 |
Point-of-care ultrasound to assess volume status and pulmonary oedema in malaria patients
|
Pugliese, Christina M. |
|
|
50 |
1 |
p. 65-82 |
artikel |
24 |
Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
|
Munker, Dieter |
|
|
50 |
1 |
p. 157-168 |
artikel |
25 |
Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease
|
Benadji, Amine |
|
|
50 |
1 |
p. 223-233 |
artikel |
26 |
SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods
|
Tatsi, Elizabeth-Barbara |
|
|
50 |
1 |
p. 251-256 |
artikel |
27 |
16S rDNA PCR for the aetiological diagnosis of culture-negative infective endocarditis
|
Anton-Vazquez, Vanesa |
|
|
50 |
1 |
p. 243-249 |
artikel |
28 |
The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy
|
Elad, Boaz |
|
|
50 |
1 |
p. 57-64 |
artikel |
29 |
The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019
|
Cui, Jiewei |
|
|
50 |
1 |
p. 121-130 |
artikel |
30 |
Tuberculous lymphadenitis: a forgotten and delayed diagnosis in low-incidence countries
|
Mathiasen, Victor Dahl |
|
|
50 |
1 |
p. 277-280 |
artikel |
31 |
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
|
Hamady, Ali |
|
|
50 |
1 |
p. 11-25 |
artikel |